Quick Heal Technologies Ltd Q4 FY2023 Concall Summary

Key Takeaways

• Consumer business collapsed unexpectedly in H2: A sudden, sharp contraction in IT software spending, driven by macroeconomic instability, pushed EBITDA negative for the quarter and blindsided management on magnitude.
• Enterprise is the durable growth engine: The enterprise segment delivered its 11th straight quarter of YoY growth, growing at a 20% CAGR over three years, and is now the company's stated future.
• Management is betting on a Q2 consumer bounce-back: The distribution channel is under stress and renewals are delayed, but leadership calls the downturn temporary and expects positive signs starting Q2 FY24.
• Investment spend stays elevated despite losses: R&D will run at 25-30% of revenue and absolute sales & marketing spend holds flat YoY; the balance sheet is zero-debt, so the company is funding through the cycle.
• What to watch next quarter: Whether the promised consumer recovery materializes in Q2, any early traction from newly launched EDR, XDR and zero-trust products, and if the enterprise revenue share marches toward the 50% target.

The Consumer Business Shock

• Sudden, deep contraction: The consumer segment, Quick Heal's 25-year cash cow, saw a steep decline in H2 FY23 as overall IT software category spend shrank, a drop management admits was far sharper than it had anticipated.
• Channel stress: Low demand pull from end consumers has created a period of stress in the distribution channel; management believes this is temporary, but it is the first time they have experienced a downturn of this nature.
• Renewals are slipping, not stopping: Customers are still renewing, but in a delayed fashion rather than immediately upon expiry, which stretches revenue recognition.
• Micro-segment exposure: The consumer product also serves micro-businesses with 4-10 PCs that buy the retail SKU, so the PC spending slowdown hit both pure consumer and very small office demand simultaneously.
• Q4 buying pattern masks early-quarter signals: Most consumer buying concentrates in Q4; the first 15 days of a new financial year typically show no change, so management deflected a question on current-quarter early signs by citing this seasonal pattern without offering specific data.

Sanjay Katkar: "Regarding the market share, there is no data available readily. But I will say, we do still command a market leading position. And it is too early to comment on this, like we are experiencing for the first time, but we have been seeing this from last quarter, and we are taking all the steps to make sure what we can do to overcome this situation."

Enterprise: The Growth Anchor

• Sustained momentum: Enterprise business grew YoY for the 11th consecutive quarter and has delivered a 20% CAGR over the last three years, making it the clear growth driver while consumer falters.
• ARPU improving: Pricing on the enterprise side is firm and ARPU has been increasing substantially over the last few years, across both retail and enterprise segments.
• Two-lever expansion plan: Management aims to grow enterprise by increasing wallet share within existing customers and by expanding the addressable customer segment from SMB up into mid-size enterprises and government.
• Addressable opportunity multiplies: Combined, these two levers expand the addressable opportunity to five to six times the current base, which the company plans to capture gradually.
• Mid-size customers already landing: A few mid-size enterprise customers have already been onboarded, and more product lines are still in the pipeline.
• Enterprise revenue share target: Management expects enterprise to reach at least 50% or more of total revenue within the next four to six quarters, a shift that would fundamentally rebalance the business mix.

New Products & Strategic Positioning

• EDR and XDR gaining early traction: Over 20 customers have been onboarded for newly launched products in the endpoint detection and response and extended detection and response space.
• Zero-trust and data privacy products in market-fit phase: These products are still being tuned for product-market fit, with revenue expected to begin flowing from Q2 FY24.
• NIST collaboration opens B2B and B2G doors: Quick Heal became the first and only Indian company to collaborate with the US National Institute of Standards and Technologies' National Cyber Security Center of Excellence on a data classification project, alongside Google and Adobe; this creates visibility for future best-practices, compliance and policy-making engagements across industries.
• AV-TEST validation: The flagship endpoint protection product achieved a perfect score across all six annual testing cycles in the protection category.
• Product iteration is a multi-release journey: New products will launch in phases through H1 and H2 FY24, but management cautioned that reaching full competitiveness with international players requires continuous feature additions across 1.0, 2.0 and subsequent iterations.

Kailash Katkar: "This is something like 1.0, 2.0 urgent. And to really make product full fledge, you need to keep on adding lot of features to make sure that you are comfortable with the international players."

Financial Health & Cost Management

• EBITDA turned negative: The quarter's EBITDA loss is attributed largely to the top-line degrowth in the consumer business, which carries high operating leverage.
• Gross margins held firm: Despite the revenue shock, gross margins remained strong and constant versus the prior year at over 95%, indicating the underlying unit economics of the software are intact.
• Receivables quality improved: Days outstanding reduced by 29 days to 114 days, returning to pre-pandemic levels, as management worked deliberately to improve the quality of revenue.
• Cost optimization underway: Total expenditure fell by Rs. 12 crore on a QoQ basis, and management committed to continuing cost optimization measures to revive profitability.
• R&D spend to stay elevated: R&D expenses, comprising largely manpower cost plus technical collaboration and cloud charges, are expected to run at 25% to 30% of revenue going forward.
• Sales & marketing leverage expected: Absolute sales and marketing spend in FY24 will remain similar to FY23 levels, so if revenue recovers, operating leverage kicks in; new products will need incremental effort, but standard products can be sold more efficiently at existing cost.
• Dividend proposed: A dividend of Rs. 2.5 per share was proposed.

The Consumer Thesis: Cyclical, Not Terminal

• Threat evolution drives demand cycles: Management's long experience suggests the consumer market moves in cycles: operating systems improve native security, then malware authors catch up with new penetration techniques, and the cycle repeats across viruses, worms, phishing, ransomware and now scams.
• OS-level security is not sufficient long-term: The argument is that built-in OS defenses eventually get bypassed, so the consumer security market will evolve into newer segments rather than diminish permanently.
• No market share data to confirm or refute share loss: When asked directly whether the drastic retail drop implies market share contraction, management said no data is readily available and it is too early to comment, leaving the question of competitive positioning unanswered.

Sanjay Katkar: "It's not going to be like a consumer market will completely diminish. It will evolve into a newer segment or a completely different kind of threats we start seeing."

Guidance & Commitments

Key Metrics